z-logo
open-access-imgOpen Access
Efficacy and immune activation of ipilimumab in early-stage lung cancer patients
Author(s) -
Shingo Noguchi,
Kazuhiro Yatera
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.05.108
Subject(s) - ipilimumab , medicine , effector , cytotoxic t cell , lung cancer , immune system , antibody , antigen , immune checkpoint , cancer , immunology , cancer research , immunotherapy , oncology , biology , in vitro , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom